Complications of ischemic heart disease

Article written and reviewed by Dr Luca Moretti

Complications of ischemic heart disease result from the interaction among reversible ischemia, necrosis, scar, electrical instability, and remodeling. They may develop within minutes as ventricular fibrillation or shock, in the following days as wall rupture, a septal defect, or acute mitral regurgitation, or over the long term as ischemic cardiomyopathy, heart failure, aneurysm, ventricular thrombus, and scar-related ventricular tachycardia.
Their frequency has been reduced, but not eliminated, by early reperfusion and secondary prevention; late presentation, extensive infarction, age, diabetes, kidney disease, previous myocardial injury, and failure to revascularize increase risk.

Surveillance must follow a temporal sequence. During the acute phase, rhythm, blood pressure, perfusion, pain, ECG, troponin, and echocardiography are monitored; every new murmur, episode of hypotension, pulmonary edema, recurrent pain, or deterioration in consciousness requires immediate reassessment. After discharge, ventricular function, congestion, arrhythmias, residual ischemia, mitral regurgitation, thrombus, and adherence define follow-up.
Treatment does not consist solely of managing an event that has already occurred: timely reperfusion, appropriate antithrombotic therapy, heart failure therapy, lipid control, rehabilitation, and devices prevent new complications and modify prognosis.

Etiology, risk factors, pathogenesis, and pathophysiology

Myocardial necrosis disrupts cellular architecture and reduces the strength of the extracellular matrix. Before the collagen scar matures, infarcted tissue passes through a vulnerable phase in which inflammation, enzymatic digestion, and wall stress may promote discontinuity; myocardial fragility is therefore dynamic. Transmural extent, intracavitary pressure, and local geometry determine which structure may fail.
Extensive infarctions, absent or late reperfusion, and poor collateral circulation increase the amount of nonviable tissue. Advanced age, a first infarction, hypertension, and certain locations have been associated with ruptures in cohorts, but no profile permits their exclusion in an individual patient; delayed presentation remains an important modifiable determinant. Early reopening of the artery limits necrosis and the likelihood of complications.

Free-wall rupture creates a communication between the ventricle and pericardial space; rapid bleeding produces hemopericardium and tamponade, whereas a slowly oozing laceration may have a subacute course. When clots, adhesions, or the pericardium contain the defect, a post-infarction ventricular pseudoaneurysm may form. Contained rupture does not represent stable healing. The cavity wall lacks normal resistant myocardium.
Septal necrosis may open a left-to-right shunt, with acute right ventricular overload and reduced systemic output. Post-infarction ventricular septal rupture may be simple or complex, particularly in inferior infarctions; the acute shunt rapidly increases pulmonary pressure. Defect size, biventricular function, and vascular resistance determine instability.

The posteromedial papillary muscle more often depends on a single arterial supply and is therefore particularly vulnerable to an inferior infarction. Partial or complete papillary muscle rupture causes sudden loss of coaptation and acute mitral regurgitation after myocardial infarction; the atrial volume load encounters an unadapted chamber. Pulmonary pressure and edema may increase within minutes.
When the wall does not rupture, a transmural infarction may expand and progressively alter ventricular shape and volume. Thinning, fiber elongation, global dilation, and neurohormonal activation fuel adverse remodeling; a post-infarction ventricular aneurysm is an expanded scar that retains the layers of the wall. Its dyskinesia diverts effective stroke volume and increases stress on residual myocardium.

Apical akinesia, endocardial injury, and the prothrombotic state of infarction fulfill Virchow's triad and promote left ventricular thrombus after myocardial infarction. Contact between transmural necrosis and the pericardium may instead cause early post-infarction pericarditis, while a delayed immune response sustains Dressler syndrome. Apical stasis and pericardial inflammation are distinct pathways requiring different therapies.
Microvascular obstruction and intramyocardial hemorrhage may enlarge injury despite angiographic reopening of the artery. Edema, obstructed capillaries, and microcirculatory compression limit recovery, promoting remodeling and arrhythmias; reperfusion injury does not negate the benefit of timely revascularization. It does, however, explain why epicardial patency does not always guarantee preserved ventricular function.

Classification, pathological anatomy, and evolution

A clinically useful classification separates electrical, hemodynamic, mechanical, thromboembolic, inflammatory, and remodeling events. Categories may overlap: septal rupture causes shock, an aneurysm sustains tachycardia and thrombus, and papillary rupture causes valvular insufficiency and congestion; a mechanistic classification avoids counting the same process as independent diseases. It primarily serves to establish diagnostic and therapeutic priorities.
Temporally, arrhythmias and pump failure may occur during initial ischemia; cardiac ruptures more often emerge within hours or the first few days; thrombus and early pericarditis may develop during hospitalization; aneurysm, chronic heart failure, monomorphic tachycardia, and Dressler syndrome are typically later. The temporal sequence nevertheless remains variable. Incomplete reperfusion or delayed diagnosis may shift the time of presentation.

Ruptures include the free wall, septum, and papillary muscle. They may be complete, partial, direct or serpiginous, explosive or slowly oozing; morphology influences shunt, bleeding, and repairability; necrotic tissue makes the lesion margin unstable. A single echocardiographic measurement does not always describe the true intramyocardial extent.
A true aneurysm contains endocardium, scarred myocardium, and pericardium, generally has a broad continuity with the cavity, and is often anterior or apical after left anterior descending artery infarction. A pseudoaneurysm is instead a pericardial cavity communicating through a rupture and occurs more often inferiorly or posterolaterally. Wall composition takes precedence over shape. The neck-to-sac ratio alone is not an absolute criterion.

Post-infarction remodeling does not necessarily coincide with a circumscribed aneurysm. It may produce diffuse dilation, spherical remodeling, functional mitral regurgitation, and progression to ischemic cardiomyopathy even without a recognizable sac; ventricular geometry alters mechanical efficiency and prognosis. End-systolic volume, ejection fraction, scar, and right ventricular function should be interpreted together.
A thrombus may be laminated, protruding, sessile, or mobile, and fresh or organized. The probability of embolism cannot be inferred from a single feature, but mobility and protrusion increase clinical concern; thrombus maturation changes during follow-up. An equivocal apical echocardiographic finding should be confirmed with contrast or MRI before imposing prolonged treatment.

Pericardial syndromes are divided into an early form caused by local extension of inflammation and a delayed immune-mediated form. Both may cause effusion, but new pericardial fluid after infarction first requires exclusion of rupture; a post-infarction effusion is not automatically benign. Distribution, rate of accumulation, hemodynamic characteristics, and hemoglobin trends guide urgency.
Complications may also be termed immediate, early, and late only for organizational purposes. A patient with an unrecognized infarction may present directly with a pseudoaneurysm or embolism without a certain date of the causal event; clinical timing should therefore include previous ECGs, biomarkers, scar, and symptom history. Temporal uncertainty should be acknowledged rather than resolved through arbitrary classification.

Clinical manifestations

Hypotension, cold skin, altered mental status, oliguria, and elevated lactate indicate hypoperfusion but do not identify its cause. After infarction, loss of contractility, persistent ischemia, right ventricular infarction, arrhythmia, hemorrhage, and a mechanical complication must be considered; post-infarction shock requires immediate echocardiography. Attributing it solely to ejection fraction may delay lifesaving repair.
A new systolic murmur suggests a septal shunt or mitral regurgitation but may be faint or absent in severe shock because the gradient and output are reduced. A thrill, radiation, prominent v waves, and congestion help without replacing Doppler; a new murmur is a warning sign, not a requirement. An apparently unimpressive physical examination does not exclude complete rupture.

Sudden dyspnea, hypoxemia, crackles, and pulmonary edema are typical of acute mitral regurgitation but also occur with a septal shunt and ventricular failure. Radiography may show asymmetric edema in eccentric regurgitation. Sudden edema should be interpreted with echocardiography. Initially preserved arterial pressure does not guarantee stability over the following hours.
Persistent or recurrent chest pain may reflect ischemia, reinfarction, pericarditis, or a subacute rupture. Pleuritic pain relieved by sitting and a friction rub point toward the pericardium, while syncope, restlessness, and electromechanical dissociation suggest tamponade; post-infarction pain must not be classified by quality alone. ECG, troponin, hemodynamics, and imaging define the new event.

Palpitations, presyncope, or syncope may result from ventricular tachycardia arising from the scar. During the acute phase, ventricular fibrillation and polymorphic tachycardia often reflect ischemia and electrical instability, whereas months later monomorphic tachycardia suggests reentry in the scar border zone; the arrhythmic phenotype changes as the infarction matures. Treatment must distinguish a reversible trigger from a persistent substrate.
Progressive heart failure, reduced exercise tolerance, orthopnea, and peripheral swelling may signal remodeling or a true aneurysm. Neurological events or peripheral ischemia may be the first manifestation of an unrecognized ventricular thrombus; a late presentation may therefore occur far from the heart. A history of a large anterior infarction increases suspicion but does not replace imaging.

Fever, asthenia, pleuritic pain, and increased inflammatory markers weeks after the event point toward Dressler syndrome, but infection, pulmonary embolism, and recurrent ischemia must be excluded. Vascular or infectious complications must also be considered after invasive procedures; post-infarction fever has many causes. An immune-mediated diagnosis requires consistent timing and absence of more urgent explanations.
The daily examination looks for changes from baseline: increased heart rate, reduced pulse pressure, new heart sounds, jugular venous distention, pulsus paradoxus, a thrill, and congestion. Its value derives primarily from observed change, not from the specificity of an individual finding; serial physical findings complement instrumental monitoring. Recording the time of onset helps correlate symptoms, medications, and images.

Investigations and diagnosis

Bedside transthoracic echocardiography is the initial cornerstone because it assesses biventricular function, regional wall motion, effusion, chamber collapse, shunt with color Doppler, and mitral regurgitation. It should be repeated if the presentation changes, even after a previous reassuring examination. Urgent ultrasonography answers immediate questions. Limited quality or an incongruent result requires a complementary method, not a false exclusion.
Transesophageal echocardiography improves visualization of the mitral apparatus, septum, and posterior structures when the transthoracic window is inadequate. In an unstable patient, it should be performed without delaying support or transfer to the operating room; the transesophageal approach is a targeted examination. Sedation, ventilation, and hemodynamic risk require coordination with intensive care and cardiac surgery.

Continuous ECG monitoring identifies arrhythmias and ischemic changes, while troponin, complete blood count, coagulation tests, renal function, blood gas analysis, and lactate quantify injury and systemic consequences. No biomarker confirms cardiac rupture; serial monitoring describes the trajectory. Falling hemoglobin with an enlarging effusion or rising lactate should accelerate imaging and decision-making.
Cardiac magnetic resonance imaging is particularly useful in stable patients for volumes, scar, viability, thrombus, and differentiation between a true aneurysm and pseudoaneurysm. Late enhancement delineates infarcted myocardium, while the absence of myocardial layers in the wall supports contained rupture; tissue characterization completes echocardiography. It is inappropriate when instability and suspected rupture require immediate intervention.

Cardiac CT offers high anatomical resolution and describes the neck, sac, calcification, thrombus, and relationships with coronary arteries and thoracic structures. It is useful for planning surgery or transcatheter closure, particularly if MRI is contraindicated; tomographic reconstruction defines access and margins. Radiation, contrast, and transport must be justified by a question capable of changing management.
Coronary angiography defines the culprit artery and anatomy for possible revascularization; ventriculography and hemodynamic measurements may show a shunt or cavity, but high-pressure injection is unnecessary if a rupture is already documented noninvasively; the invasive strategy must avoid unnecessary delays and risks. The benefit of knowing coronary anatomy is balanced against stability and time to repair.

Principles for recognizing a post-infarction complication

• New clinical or hemodynamic deterioration after a documented infarction.
• Immediate integration of physical examination, ECG, monitoring, and echocardiography.
• Definition of the mechanism: pump failure, arrhythmia, rupture, valvular disease, thrombus, or pericarditis.
• Advanced imaging only if compatible with stability and capable of changing the decision.
• Early discussion with a cardiac surgery center for every suspected mechanical complication.

The differential diagnosis includes reinfarction, stent thrombosis, aortic dissection, pulmonary embolism, hemorrhage, sepsis, a drug reaction, and respiratory causes. Multiple processes may coexist, such as shock from an extensive infarction worsened by mitral regurgitation; an integrated diagnosis does not necessarily seek a single cause. The contribution of each mechanism to current compromise should be quantified.
Right heart catheterization is not required to diagnose every complication but may clarify complex shock when echocardiography and clinical findings disagree. Pressures, output, and saturations permit recognition of a shunt and guide support without replacing anatomical visualization; hemodynamic profiling is selective. Catheter placement must have a purpose and must not delay an already indicated correction.

Treatment and prognosis

The first preventive measure is to reduce ischemic time through recognition of infarction and timely reperfusion. After the acute phase, antithrombotic therapy, intensive lipid lowering, risk factor control, and rehabilitation reduce recurrences and promote recovery; secondary prevention remains necessary even after successful repair. Correcting the complication does not eliminate the causal coronary disease.
During acute deterioration, hypoxemia, arrhythmias, and hypoperfusion are treated while avoiding interventions that worsen the mechanism. Vasodilators may be useful in mitral regurgitation if pressure permits but harmful in shock; excessive fluids may worsen edema and shunting; physiological stabilization is specific to the lesion. Support must not become an indefinite postponement of necessary repair.

Free-wall rupture, septal defect, and papillary rupture require urgent cardiac surgical consultation. Optimal timing depends on shock, anatomy, and tissue friability: waiting for a stronger scar may facilitate some repairs but is impossible in unstable patients; the timing decision balances immediate and operative risks. It must be continuously reassessed by a multidisciplinary team.
Circulatory support devices may create a bridge to repair or recovery in selected patients. The choice among an intra-aortic balloon pump, microaxial pumps, extracorporeal oxygenation, or combined configurations depends on the lesion, compromised ventricle, and center experience; mechanical support is not neutral. Bleeding, limb ischemia, hemolysis, and modification of shunts must be considered before implantation.

A true aneurysm is initially treated with heart failure therapy, ischemic prevention, and management of arrhythmias or thrombus. Ventricular reconstruction is not automatically added to bypass surgery because it did not improve the primary outcome in the randomized STICH population; surgical selection considers refractory symptoms, geometry, viability, arrhythmias, and emboli. A pseudoaneurysm, as a contained rupture, instead requires early evaluation for repair.
Documented ventricular thrombus is anticoagulated according to morphology and embolic and bleeding risks, with follow-up imaging to verify resolution. Pericarditis is treated while preserving post-infarction healing and considering interactions with antithrombotic therapy; causal treatment avoids undifferentiated protocols. An anticoagulant or anti-inflammatory drug should not be prescribed merely because the patient has had an infarction.

Prognosis is extremely heterogeneous. A rupture with shock carries an extremely high immediate risk, whereas a small inflammatory effusion may resolve; a stable aneurysm may be followed for years, but heart failure, tachycardia, and thrombus worsen its course; residual risk depends on ventricular function, scar, and comorbidities. Follow-up and rehabilitation should include clear instructions for new symptoms.
After discharge, ventricular volume and function are reassessed when recovery may change treatment or indications for devices. Blood pressure, heart rate, renal function, and potassium guide drug titration; adherence and tolerability should be directly verified; scheduled reassessment avoids definitive decisions during the transient phase. Timing depends on severity, the procedure performed, and residual findings.

Acute heart failure after ischemia is not a uniform entity. It may result from extensive loss of contractile myocardium, potentially reversible stunning, persistent ischemia, right ventricular infarction, mitral regurgitation, an arrhythmia, or iatrogenic volume overload; before intensifying diuretics and vasodilators, the hemodynamic phenotype must therefore be recognized. Congestion with preserved blood pressure, hypoperfusion with elevated filling pressures, and right-sided shock require different strategies, while serial echocardiography makes it possible to observe recovery from stunning or the emergence of a mechanical complication that was not initially evident.
When left ventricular injury predominates, diuretics, oxygenation, and vasodilation are adjusted according to blood pressure and perfusion; in the presence of hypotension, inotropes may temporarily support output, but they increase oxygen consumption and arrhythmic potential. Their use must therefore have a defined objective, such as bridging to revascularization, repair, or mechanical support, preventing transient improvement in hemodynamic numbers from replacing treatment of the reversible cause.

Infarct-related cardiogenic shock requires urgent revascularization of the culprit lesion and complete anatomical assessment, but in patients with multivessel disease, routine immediate PCI of all nonculprit stenoses may increase the procedural burden without improving outcome. The strategy must distinguish the culprit vessel from lesions to be treated later, except in exceptional anatomical or ischemic circumstances. Hypoxemia, acidosis, arrhythmias, temperature abnormalities, and metabolic disturbances are corrected in parallel because the spiral of hypoperfusion reduces coronary perfusion and the response to vasopressors.
Dynamic staging of shock is more useful than a static label: an initially normotensive patient may have rising lactate and peripheral vasoconstriction, whereas another may maintain low blood pressure with acceptable perfusion. Lactate trajectory, urine output, mental status, liver and kidney function, ultrasound, and vasoactive drug dose describe the course. The shock team, when available, integrates interventional cardiology, intensive care, cardiac surgery, and advanced heart failure specialists to select the goals and limits of support promptly.

Recurrent ischemia in the following hours or days may result from stent thrombosis, dissection, distal embolization, spasm, a residual lesion, or a systemic increase in demand. Pain is not always present, and new ST-segment changes, arrhythmias, instability, or new regional dysfunction may be the only sign. Diagnosis requires comparison with the post-procedural tracing and biomarkers, whose kinetics must be interpreted in the context of injury already under way; a new rise in troponin, in isolation, does not demonstrate reinfarction without additional evidence of ischemia.
Acute or subacute stent thrombosis is an angiographic emergency and must prompt investigation for premature discontinuation of antiplatelet therapy, underexpansion, malapposition, edge dissection, or a prothrombotic state. IVUS or OCT may identify the mechanism and guide correction because simply adding another stent without understanding the failure risks perpetuating the procedural cause.

Right ventricular involvement profoundly changes management. A reduction in preload due to nitrates, aggressive diuresis, or hypovolemia may precipitate hypotension; conversely, indiscriminate fluid loading distends the right ventricle, shifts the septum, and worsens left ventricular filling. Venous pressure, echocardiography, the response to small boluses, and signs of congestion guide cautious titration, while reperfusion of the culprit artery remains the decisive measure.
Bradycardia and atrioventricular block may further reduce output in inferior infarction. Atropine and temporary pacing are used according to the site and instability, but recovery of conduction after reperfusion is common in nodal blocks. An infranodal block with anterior infarction, by contrast, indicates extensive injury and is associated with greater risk, requiring monitoring and immediate availability of pacing.

Prevention of adverse remodeling continues beyond hospitalization. Renin-angiotensin system inhibition, beta-blockade, mineralocorticoid receptor antagonists, and SGLT2 inhibitors are introduced in appropriate patients according to ventricular function, symptoms, blood pressure, kidney function, and potassium; gradual titration prevents hypotension or kidney failure from permanently interrupting prognostic therapies. Ejection fraction measured during ischemia, edema, and stunning must not be regarded as immutable but reassessed after revascularization and optimized therapy when the result may change the indication for an ICD or CRT.
Complete revascularization is also planned over time. Residual lesions, viability, ischemia, symptoms, and anatomical complexity are discussed while distinguishing the prognostic objective from relief of angina. Functional recovery depends on the amount of stunned or hibernating myocardium relative to irreversible scar, but no viability test, in isolation, guarantees a survival benefit from the procedure.

The risk of bleeding is an integral part of the complications because reperfusion, arterial access, antiplatelet agents, and anticoagulants may cause access-site, gastrointestinal, retroperitoneal, or intracranial hemorrhage. A drop in blood pressure after PCI must not automatically be attributed to cardiogenic shock: examination of access sites, complete blood count, ultrasound, and targeted CT, when compatible with urgency, make it possible to identify occult blood loss. Selection of radial access, correct drug dosing, and shorter durations of antithrombotic combinations in high-risk patients reduce exposure without relinquishing necessary ischemic protection.
When ventricular thrombus, atrial fibrillation, or another indication for anticoagulation coexists, the regimen must balance embolic prevention against the risk of triple therapy. Duration, drug type, and timing of simplification are individualized according to time since PCI, coronary complexity, previous bleeding, age, and kidney function; the ischemic-bleeding balance is reassessed at every transition of care.

Complications

The final common pathway of major hemodynamic complications is shock, cardiogenic when due to loss of contractility, a shunt, or mitral regurgitation, and obstructive in the case of tamponade. The mechanisms may overlap and produce multiorgan failure, acidosis, and coagulopathy; refractory shock reduces the likelihood that any procedure will succeed. Early recognition and transfer are therefore integral parts of treatment.
Free rupture may progress to tamponade and arrest with pulseless electrical activity. A pseudoaneurysm may rupture again, while a septal defect may enlarge in necrotic tissue and partial papillary rupture may progress; anatomical progression justifies close surveillance. Transient improvement does not demonstrate that the lesion has stabilized.

The post-infarction scar creates slow-conduction channels that sustain monomorphic ventricular tachycardia. A reduced ejection fraction increases the risk of sudden death, but risk stratification for a defibrillator must respect guideline timing and criteria; the scar substrate may require medication, ablation, and a device. Intervention on an aneurysm does not automatically replace indicated arrhythmic protection.
Stasis and thrombus may cause stroke or mesenteric, renal, or peripheral ischemia. Emboli may occur before the thrombus is recognized or despite treatment, while anticoagulation increases bleeding risk in a patient often already treated with antiplatelet agents; the thrombotic-bleeding balance must be reassessed. Treatment duration and combinations are not the same for everyone.

Remodeling may progress to chronic heart failure, functional mitral regurgitation, pulmonary hypertension, and right ventricular dysfunction. Recurrent admissions, cachexia, and renal failure indicate an advanced phase that may require ventricular assistance or transplantation in appropriate candidates; ischemic cardiomyopathy is a systemic sequela. Preventing dilation is more effective than treating only its terminal stages.
Pericarditis may recur or produce a significant effusion; inflammatory tamponade is less common but must be distinguished from bleeding. Antithrombotic therapy, renal function, and gastrointestinal risk complicate drug selection; pericardial recurrence requires confirmation of inflammatory activity. Isolated pain without objective signs requires reconsideration of alternative diagnoses.

The procedures themselves may cause bleeding, stroke, renal failure, infection, vascular injury, hemolysis, or lesion recurrence. After surgical or transcatheter repair, imaging and clinical follow-up consistent with the technique and material used are required; procedural iatrogenesis enters the overall prognosis. Communication between the interventional center and community follow-up reduces omissions and duplication.
A less measurable complication is loss of independence after intensive care, surgery, and prolonged hospitalization. Acquired weakness, anxiety, depression, and fear of exertion may limit recovery even when repair is anatomically sound; multidimensional rehabilitation includes exercise, nutrition, and psychological support. Functional goals should be shared with the patient and caregivers.

Electrical complications include ectopy, ventricular tachycardia, ventricular fibrillation, atrial fibrillation, bradycardia, and atrioventricular block. Acute ischemia creates heterogeneous conduction and refractoriness; chronic scar forms channels of slow conduction. Defibrillation, reperfusion, electrolyte correction, beta-blockade, an ICD, and ablation are selected according to phase, rhythm, and reversibility.
Pump dysfunction ranges from mild congestion to cardiogenic shock; myocardial loss, persistent ischemia, right ventricular involvement, and mechanical complications may coexist, making immediate echocardiography essential.

Over the long term, dilation and remodeling promote secondary mitral regurgitation, aneurysm, thrombus, embolism, heart failure, and sudden death. Early pericarditis reflects inflammation contiguous with necrosis, whereas Dressler syndrome is a later post-cardiac injury syndrome. Depression, deconditioning, and reduced quality of life are clinically relevant complications and influence adherence and recovery.
Prognosis depends on the speed of recognition and residual reserve: new instability must not be generically attributed to infarction but urgently traced to its correctable mechanism.